Uplizna was approved in the United States on August 26, 2025, and the acquisition of Horizon Therapeutics boosted revenues.

The entities involved

• Amgen →

  American multinational biopharmaceutical company

  • Amgen, City of Hope, and the California Community Foundation are involved in a life sciences and bioscience economic summit held in Downtown Los Angeles.Mon 12:08
  • Geode Capital Management increased its stake in Amgen stock and filed the disclosure with the SEC.Mon 02:05
• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Horizon Therapeutics →

  Irish tax-registered pharmaceutical

  Nothing else this week.

Related events

• BioXcel Therapeutics received FDA approval for its drug and announced results from New Haven.Jun 7
• Amylyx Pharmaceuticals is seeking FDA approval for a new drug treatment.Aug 18
• MMJ International Holdings is pursuing FDA-approved cannabinoid medicines.Jul 14
• The FDA recommended advancement for a new drug application submitted by a company.Jun 8
• A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.Jun 7